|
TFG expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.56680000032539E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.52709999998469E-06 |
| Normal-vs-Stage2 |
2.03290000000411E-06 |
| Normal-vs-Stage3 |
7.80419999735216E-08 |
| Normal-vs-Stage4 |
9.17650000431536E-09 |
| Stage1-vs-Stage2 |
1.615960E-01 |
| Stage1-vs-Stage3 |
5.356200E-02 |
| Stage1-vs-Stage4 |
1.004040E-02 |
| Stage2-vs-Stage3 |
9.834000E-01 |
| Stage2-vs-Stage4 |
5.862000E-01 |
| Stage3-vs-Stage4 |
5.318800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.08119998801726E-09 |
| Normal-vs-AfricanAmerican |
6.937600E-01 |
| Normal-vs-Asian |
1.77228999999057E-05 |
| Caucasian-vs-AfricanAmerican |
1.188170E-01 |
| Caucasian-vs-Asian |
7.051800E-01 |
| AfricanAmerican-vs-Asian |
1.627780E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.69460999999149E-05 |
| Normal-vs-Female |
3.00539999997795E-07 |
| Male-vs-Female |
5.724000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.52753000000061E-05 |
| Normal-vs-Age(41-60Yrs) |
3.75659999996003E-07 |
| Normal-vs-Age(61-80Yrs) |
1.24979999682751E-08 |
| Normal-vs-Age(81-100Yrs) |
9.473600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.601800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.924200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.587800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.072800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.302800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.113200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.094000E-01 |
| Classical-VS-Follicular |
6.304800E-01 |
| Classical-VS-Other |
4.244000E-01 |
| Classical-VS-Normal |
5.82260000214774E-08 |
| Tall-VS-Follicular |
1.786800E-01 |
| Tall-VS-Other |
8.795600E-01 |
| Tall-VS-Normal |
4.48570000000093E-06 |
| Follicular-VS-Other |
5.432000E-01 |
| Follicular-VS-Normal |
2.235800E-03 |
| Other-VS-Normal |
8.403000E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.10459999614588E-08 |
| Normal-vs-N1 |
1.82690000016805E-07 |
| N0-vs-N1 |
4.470800E-01 |
|
|
